Login / Signup
Oguzhan Okcu
(Oğuzhan Okcu)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 7
Top Topics
Blood Glucose
Benign Prostatic Hyperplasia
Rectal Cancer
Locally Advanced
Top Venues
Revista da Associacao Medica Brasileira (1992)
International journal of surgical pathology
Andrologia
Cellular oncology (Dordrecht)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Seda Duman Öztürk
,
Çiğdem Öztürk
,
Oguzhan Okcu
,
Gokce Askan
,
Bayram Sen
,
Recep Bedir
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer.
Revista da Associacao Medica Brasileira (1992)
69 (3) (2023)
Seda Duman Öztürk
,
Çiğdem Öztürk
,
Oguzhan Okcu
,
Gokce Askan
,
Bayram Sen
,
Recep Bedir
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer.
Revista da Associacao Medica Brasileira (1992)
69 (3) (2023)
Seda Duman Öztürk
,
Çiğdem Öztürk
,
Oguzhan Okcu
,
Gokce Askan
,
Bayram Sen
,
Recep Bedir
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer.
Revista da Associacao Medica Brasileira (1992)
69 (3) (2023)
Çiğdem Öztürk
,
Oguzhan Okcu
,
Bayram Sen
,
Recep Bedir
An easy and practical prognostic parameter: tumor-stroma ratio in Luminal, Her2, and triple-negative breast cancers.
Revista da Associacao Medica Brasileira (1992)
68 (2) (2022)
Oguzhan Okcu
,
Bayram Şen
,
Gokce Askan
,
Çiğdem Öztürk
,
Seda Duman Öztürk
,
Recep Bedir
Tumor Budding is an Independent Prognostic Factor to Predict Overall Survival in Endometrial Endometrioid Carcinoma: A Retrospective Study.
International journal of surgical pathology
(2022)
Medeni Arpa
,
Bayram Sen
,
Huseyin Eren
,
Hakkı Uzun
,
Oguzhan Okcu
,
Ozcan Erel
Total thiol can contribute to differentiating prostate cancer from BPH: Prostate Thiol Index as a new player.
Andrologia
53 (10) (2021)
Mehmet Zengin
,
Sema Zergeroğlu
,
Oguzhan Okcu
,
Suat Benek
PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer.
Cellular oncology (Dordrecht)
44 (2) (2021)